MDNA Life Sciences Units (Proposed)
MDLS0.0000.00%
收盘 02/06, 16:00（美东）报价延迟15分钟
--总市值
--市盈率 TTM
关于 MDNA Life Sciences Units (Proposed) 公司
MDNA Life Sciences Inc is a United States-based company. It develops and commercializes diagnostic tests for the detection of disease in humans. The Company's products include mitochondrial deoxyribonucleic acid (DNA) test (MDNA Test) for prostate cancer detection, mitomics test for human chorosomes, and mitomic DNA test for non-invasive uterine fibrocarcinoma (NFT). Its products are used to detect diseases such as prostate cancer, endometriosis, skin cancer and UV damage.
MDNA Life Sciences Units (Proposed)简介
公司代码MDLS
公司名称MDNA Life Sciences Inc
上市日期- -
CEOMitton (Christopher C)
员工数量12
证券类型Unit
年结日- -
公司地址2054 Vista Parkway,
城市WEST PALM BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33411
电话18443216362
网址https://mdnalifesciences.com/
公司代码MDLS
上市日期- -
CEOMitton (Christopher C)
MDNA Life Sciences Units (Proposed)公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Harry Smart
Mr. Harry Smart
Chairman of the Board
Chairman of the Board
--
--
Dr. Robert Thayer, Ph.D.
Dr. Robert Thayer, Ph.D.
Independent Director
Independent Director
--
--
Mr. Christopher Hill
Mr. Christopher Hill
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Harry Smart
Mr. Harry Smart
Chairman of the Board
Chairman of the Board
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
持股股东
股东类型
持股股东
持股股东
占比
其他
100.00%
持股股东
持股股东
占比
其他
100.00%
股东类型
持股股东
占比
其他
100.00%
机构持股
由于公司未披露，未能获取相关数据
报告期
机构数
持股数
持股占比
持股变动
暂无数据
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
暂无数据
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
